Zydus Lifesciences Price Change Analysis
Zydus Lifesciences Key Statistics
-
P/E Ratio
34.5
-
PEG Ratio
0.1
-
Market Cap Cr
37504.8
-
Price to Book Ratio
129.3
-
EPS
10.7
-
Dividend
250 ()
-
Relative Strength Index
61.98
-
Money Flow Index
80.13
-
MACD Signal
-3.56
-
Average True Range
11.66
Investment Ratings
-
Master Rating:
-
EPS Strength
Price Strength
Buyer Demand
Group Rank
Result Highlights
Zydus Lifesciences Synopsis
NSE-Medical-Generic Drugs
Zydus Lifesciences is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 7790.40 Cr. and Equity Capital is Rs. 102.40 Cr. for the Year ended 31/03/2021. Zydus Lifesciences Ltd. is a Public Limited Listed company incorporated on 15/05/1995 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1995PLC025878 and registration number is 025878.-
Market Cap
37,366.62
-
Sales
7,981.90
-
Shares in Float
-
No of Funds
182
-
Yield
0.68
-
Book Value
2.85
-
U/D Vol Ratio
1.5
-
LTDebt/Equity
1
-
Alpha
-0.22
-
Beta
0.91
Zydus Lifesciences Ownership
| Owner Name | Jun-21 |
|---|---|
| Promoters | 74.88% |
| Mutual Funds | 5.83% |
| Insurance Companies | 4.18% |
| Foreign Portfolio Investors | 4.65% |
| Financial Institutions/ Banks | 0.41% |
| Individual Investors | 7.31% |
| Others | 2.74% |
Zydus Lifesciences Management
| Name | Designation |
|---|---|
| Mr. Pankaj R Patel | Chairman |
| Dr. Sharvil P Patel | Managing Director |
| Mr. Ganesh N Nayak | Executive Director |
| Mr. Bhadresh K Shah | Independent Director |
| Mr. Mukesh M Patel | Non Executive Director |
| Mr. Nitin R Desai | Independent Director |
| Ms. Dharmishtaben N Raval | Independent Woman Director |
| Ms. Apurva S Diwanji | Independent Director |
Zydus Lifesciences Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Eps And Sales Estimates
Zydus Lifesciences Financials
- Quarterly P&L
- Annual P&L
- Cash Flow
- Balance Sheet
- Ratios
Zydus Lifesciences Technicals
EMA & SMA
CURRENT PRICE
EMA
Zydus Lifesciences Resistance and Support
Zydus Lifesciences Delivery and Volume
Zydus Lifesciences Price Change Analysis
Corporate Action
Similar Stocks
| Company Name | 52 Week () |
Market Price () | Volume |
|---|
Videos
About Company
News
FAQs
Zydus Lifesciences share price is